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nents of eating behaviour, dietary intakes or physical activity did not 
differ either between groups. 
Conclusion: In this large case-control study on functional MC4R muta-
tions carriers, we have shown that MC4R mutations do not affect dietary 
intakes or eating behaviours.
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Introduction: It is generally accepted that weight loss has significant 
physiological benefits, such as reduced risk of diabetes, lowered blood 
pressure and blood lipid levels. However, few behavioural and dietary 
interventions have investigated psychological benefit as the primary 
outcome. 
Method: Systematic review methodology was adopted to evaluate the 
psychological outcomes of weight loss following participation in a 
behavioural and/or dietary weight loss intervention in overweight/obese 
populations. 35 studies were selected for inclusion and were reviewed. 
Results: Changes in self-esteem, depressive symptoms, body image and 
health related quality of life (HRQoL) were evaluated and discussed. 
The results demonstrated consistent improvements in psychological 
outcomes concurrent with and sometimes without weight loss. Im-
provements in body image and HRQoL (especially vitality) were closely 
related to changes in weight. 
Conclusion: Although the quality of the studies reviewed was generally 
acceptable, only 8 out of 35 studies included a suitable control/com-
parison group and the content, duration of intervention and measures 
used to assess psychological outcomes varied considerably. Further 
research is required to improve the quality of studies assessing the 
benefits of weight loss to fully elucidate the relationship between weight 
loss and psychological outcomes. 
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Introduction: Gastric bypass (GBP) is associated with long-term weight 
loss (WL). However, there is an important interindividual variability of 
WL after GBP with some subjects being less responsive than others. 
Previous studies identified predictive factors of WL but none explored 
tissue specific parameters such as adipose tissue remodelling. We aimed 
to determine presurgical predictors of WL after GBP by exploring these 
parameters.  
Methods: The study enrolled 404 obese candidates for bariatric surgery. 
Liver biopsies, subcutaneous (scWAT) and omental adipose tissue were 
collected. 243 patients were clinically characterized before, 3, 6, and 12 
months after surgery. Liver and scWAT stiffness were assessed non-
invasively using Vibration-Controlled-Transient-Elastography (Fi-
broscan® and a novel prototype named AdipoScan™) in 72 patients. 
Results: The exploration of BMI trajectories revealed that 28.8% of the 
participants were less responsive (LR) than others. LR group was older, 
had higher frequency of diabetes and increased circulating concentra-
tions of IL6. LR group also showed increased amount of scWAT fibro-
sis and a higher frequency of liver fibrosis. We built two predictive 
models for the less response to WL. Model1 combines scWAT fibrosis, 
HBA1C, IL6, age and BMI. Model2 combines histological parameters 
of liver, IL6 and age. Liver and scWAT stiffness were positively corre-
lated with liver and scWAT fibrosis. 
Conclusion: Altered BMI response to GBP can be predicted by a series 
of bioclinical variables, which include not only metabolic and inflamma-
tory parameters but also scWAT and liver fibrosis. Therefore the non-
invasive evaluation of liver and scWAT seems to have an interest in 
clinical practice.
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Aims: We studied in this study the effect of the Levemir insulin therapy
over the weight curve and the advantages of the using of basal insulin 
analogues.
Method: We included 120 obese patients with type 2 diabetes, to who 
we initiated the basal insulinic therapy. 
We created 2 plots: one of 60 patients who were treated with basal 
human insulin, and the second one of 60 patients who were treated with 
basal insulinic analogues- Levemir. During an interval of 6 months, the 
patients were monitored the metabolic control, body weight, BMI, 
HOMA index, waist and hip circumferences.
Results: At initializing of the study, the patients had an average Hb A1c 
of 9.8%, while after 6 months of therapy the patients out of the first plot 
ranged a Hb A1c value of 8.2% vs. the second plot with a range of 7.3%
The frequency rate of nonsevere hypoglycemic episodes was  39% and 
of the severe episodes was with 12% for first plot vs 21 % and 5% for 
second plot. The patient’s weight increase was smaller in the second 
batch. They presented an average increase of 3,8 kg within 6 months for 
first plot vs 1.2 kg for second plot.
Conclusions: The use of basal insulin analogues in the therapy of obese 
diabetic patients ensures a great benefit, as it allows a good metabolic 
control with the price of a lower hypoglycemic risk and a reduced 
weight increase in comparison to the   basal human insulin.
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Introduction: Programmes around the UK use various methods to 
trigger weight change. This work refers to a Tier 3 multidisciplinary 
(MDT) programme for patients with BMI >35 kgm2 (+ co-morbidities) 
or BMI >40 kgm2 (- co-morbidities). The MDT includes registered 
dietitians, anthropometrists, clinical psychologists and a bariatric physi-
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